
3FDF C 2,14,3.5,0.0106,0.9,14.3,Crystal Structure Of The Serine Phosphatase Of Rna Polymerase Ii Ctd (Ssu72 Superfamily) From Drosophila Melanogaster. Orthorhombic Crystal Form. Northeast Structural Genomics Consortium Target Fr253ÿ
2VY5 A ,12,3.3,0.0251,0.9,8.3,U11-48k Chhc Zn-Finger Protein Domainÿ
4IDX C 1,12,3.5,0.0180,0.9,0.0,Hexameric Crystal Structure Of Schmallenberg Virus Nucleoprotein
4ZKT B 4,17,3.3,0.0265,0.9,5.9,Crystal Structure Of The Progenitor M Complex Of Clostridium Botulinum Type E Neurotoxin
3J81 S 1,13,3.5,0.0159,0.9,7.7,Cryoem Structure Of A Partial Yeast 48s Preinitiation Complex
3N4D B 2,13,3.3,0.0425,0.9,15.4,Crystal Structure Of Cg10062 Inactivated By(R)-Oxirane-2-Carboxylateÿ
3N4D I 2,14,3.3,0.0449,0.9,14.3,Crystal Structure Of Cg10062 Inactivated By(R)-Oxirane-2-Carboxylateÿ
4YGX B 2,14,3.5,0.0106,0.9,14.3,Crystal Structure Of D. Melanogaster Ssu72+symplekin Bound To Cis Peptidomimetic Ctd Phospho-ser5 Peptide
4GEB A 1,18,3.5,0.0189,0.9,0.0,Kynurenine Aminotransferase Ii Inhibitors
4AIB C 1,19,5.2,0.0080,1.0,15.8,Crystal Structure Of Ornithine Decarboxylase From Entamoeba Histolytica
4CJ7 B 4,14,3.5,0.0477,1.0,7.1,Structure Of Crenactin, An Archeal Actin-like Protein
3N4G B 2,14,3.3,0.0473,1.0,14.3,Crystal Structure Of Native Cg10062ÿ
4BQL C 3,14,3.5,0.0477,1.0,7.1,Crystal Structure Of Archaeal Actin
3FDF D 2,13,3.4,0.0281,1.0,15.4,Crystal Structure Of The Serine Phosphatase Of Rna Polymerase Ii Ctd (Ssu72 Superfamily) From Drosophila Melanogaster. Orthorhombic Crystal Form. Northeast Structural Genomics Consortium Target Fr253ÿ
3LYV E ,29,4.3,0.0395,1.1,13.8,Crystal Structure Of A Domain Of Ribosome-Associated Factor Streptococcus Pyogenes Serotype M6. Northeast Structural Ge Consortium Target Id Dr64aÿ
3N4G A 2,12,3.4,0.0271,1.1,8.3,Crystal Structure Of Native Cg10062ÿ
4MMS D 2,12,3.5,0.0159,1.1,0.0,Crystal Structure Of Prefusion-stabilized Rsv F Variant Cav1 At Ph 5.5
3R4I E 2,13,3.4,0.0398,1.1,7.7,Crystal Structure Of A Citrate Lyase (Bxe_b2899) From Burkholderia Xenovorans Lb400 At 2.24 A Resolutionÿ
3R4I F 2,13,3.4,0.0435,1.1,7.7,Crystal Structure Of A Citrate Lyase (Bxe_b2899) From Burkholderia Xenovorans Lb400 At 2.24 A Resolutionÿ
3CW1 L ,12,3.5,0.0106,1.1,0.0,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
3CW1 L 1,12,3.5,0.0053,1.1,0.0,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
3CW1 9 ,12,3.5,0.0106,1.1,0.0,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
3CW1 9 1,12,3.5,0.0053,1.1,0.0,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
3CW1 0 ,12,3.5,0.0106,1.1,0.0,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
3CW1 0 1,12,3.5,0.0053,1.1,0.0,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
4BQL B 4,17,3.5,0.0477,1.1,11.8,Crystal Structure Of Archaeal Actin
3LYV A ,29,5.1,0.0013,1.1,13.8,Crystal Structure Of A Domain Of Ribosome-Associated Factor Streptococcus Pyogenes Serotype M6. Northeast Structural Ge Consortium Target Id Dr64aÿ
1XNQ M 1,12,3.4,0.0405,1.1,8.3,Structure Of An Inosine-Adenine Wobble Base Pair Complex In The Context Of The Decoding Center
4OVV B ,19,4.8,0.0055,1.1,5.3,Crystal Structure Of Pi3k In Complex With Lipids
4OVV B 1,19,4.8,0.0055,1.1,5.3,Crystal Structure Of Pi3k In Complex With Lipids
3R4I D 2,13,3.4,0.0386,1.1,7.7,Crystal Structure Of A Citrate Lyase (Bxe_b2899) From Burkholderia Xenovorans Lb400 At 2.24 A Resolutionÿ
3R4I C 2,13,3.4,0.0389,1.1,7.7,Crystal Structure Of A Citrate Lyase (Bxe_b2899) From Burkholderia Xenovorans Lb400 At 2.24 A Resolutionÿ
3R4I B 2,13,3.4,0.0366,1.1,7.7,Crystal Structure Of A Citrate Lyase (Bxe_b2899) From Burkholderia Xenovorans Lb400 At 2.24 A Resolutionÿ
3R4I A 2,13,3.4,0.0413,1.1,7.7,Crystal Structure Of A Citrate Lyase (Bxe_b2899) From Burkholderia Xenovorans Lb400 At 2.24 A Resolutionÿ
3N4D A 2,12,3.3,0.0450,1.2,8.3,Crystal Structure Of Cg10062 Inactivated By(R)-Oxirane-2-Carboxylateÿ
5FIK S 2,12,3.5,0.0053,1.2,8.3,Bovine Mitochondrial Atp Synthase State 3a
4BQL A 3,16,3.5,0.0477,1.2,12.5,Crystal Structure Of Archaeal Actin
4MMS B 2,12,3.5,0.0159,1.2,0.0,Crystal Structure Of Prefusion-stabilized Rsv F Variant Cav1 At Ph 5.5
3CW1 l ,13,3.5,0.0106,1.2,15.4,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
3CW1 l 1,13,3.5,0.0053,1.2,15.4,Crystal Structure Of Human Spliceosomal U1 Snrnpÿ
4F9A D 1,12,3.3,0.0226,1.2,8.3,Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
2VRD A 1,12,3.3,0.0303,1.2,0.0,The Structure Of The Zinc Finger From The Human Spliceosomal Protein U1c
4MMT B 2,20,3.5,0.0159,1.2,10.0,Crystal Structure Of Prefusion-stabilized Rsv F Variant Ds-cav1 At Ph 9.5
4BQL D 4,18,3.5,0.0477,1.2,11.1,Crystal Structure Of Archaeal Actin
4CJ7 A 4,18,3.5,0.0477,1.2,11.1,Structure Of Crenactin, An Archeal Actin-like Protein
4F99 B 1,12,3.3,0.0320,1.2,16.7,Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
1GJZ A ,24,3.5,0.0053,1.2,4.2,Solution Structure Of A Dimeric N-Terminal Fragment Of Human Ubiquitin
1GJZ B ,24,3.5,0.0053,1.2,4.2,Solution Structure Of A Dimeric N-Terminal Fragment Of Human Ubiquitin
5A9Q a 2,18,5.2,0.0297,1.3,0.0,Human Nuclear Pore Complex
1IBM M ,12,3.7,0.0483,1.3,8.3,Structure Of The Thermus Thermophilus 30s Ribosomal Subunit In Complex With A Messenger Rna Fragment And Cognate Transfer Rna Anticodon Stem-Loop Bound At The A Siteÿ
1HNW M ,12,3.8,0.0385,1.3,8.3,Structure Of The Thermus Thermophilus 30s Ribosomal Subunit In Complex With Tetracycline
1Q20 A 1,15,3.2,0.0491,1.3,0.0,Crystal Structure Of Human Cholesterol Sulfotransferase (Sult2b1b) In The Presence Of Pap And Pregnenolone
3OMW B 2,18,3.5,0.0106,1.3,11.1,Crystal Structure Of Ssu72, An Essential Eukaryotic Phosphatase Specific For The C-Terminal Domain Of Rna Polymerase Iiÿ
4E4K A ,17,6.0,0.0120,1.3,5.9,Crystal Structure Of Ppargamma With The Ligand Jo21
2Q6R A ,17,6.0,0.0120,1.3,0.0,Crystal Structure Of Ppar Gamma Complexed With Partial Agonist Sf147
4HRS A ,17,3.2,0.0350,1.3,5.9,Crystal Structure Of H. Volcanii Small Archaeal Modifier Protein 2
3N4D H 2,18,3.3,0.0261,1.3,11.1,Crystal Structure Of Cg10062 Inactivated By(R)-Oxirane-2-Carboxylateÿ
3V8V B 2,19,3.5,0.0477,1.3,0.0,Crystal Structure Of Bifunctional Methyltransferase Ycby (Rlmlk) From Escherichia Coli, Sam Bindingÿ
2M9A A ,13,3.5,0.0343,1.3,0.0,Solution Nmr Structure Of E3 Ubiquitin-protein Ligase Zfp91 From Homo Sapiens, Northeast Structural Genomics Consortium (nesg) Target Hr7784a
3WMH B ,18,6.0,0.0120,1.3,5.6,Human Pprr Gamma Ligand Binding Domain In Complex With A Gammma Selective Synthetic Partial Agonist Mekt75

4DUY M ,12,3.8,0.0420,1.3,8.3,Crystal Structure Of The Thermus Thermophilus 30s Ribosomal Subunit With A 16s Rrna Mutation, U13c
4TTQ A 2,12,3.9,0.0445,1.3,8.3,Crystal Structure Of Legionella Pneumophila Dephospho-coa Kinase In Complex With Atp
4NTX A 3,12,3.4,0.0492,1.3,8.3,Structure Of Acid-sensing Ion Channel In Complex With Snake Toxin And Amiloride
4PRG D ,17,5.7,0.0373,1.3,0.0,0072 Partial Agonist Ppar Gamma Cocrystal
2GRJ A 2,12,3.5,0.0318,1.3,8.3,Crystal Structure Of Dephospho-Coa Kinase (Ec 2.7.1.24) (Dephosphocoenzyme A Kinase) (Tm1387) From Thermotoga Maritima At 2.60 A Resolution
4NTW A 3,12,3.4,0.0457,1.3,8.3,Structure Of Acid-sensing Ion Channel In Complex With Snake Toxin
4O8F B ,19,6.0,0.0120,1.3,0.0,Crystal Structure Of The Complex Between Ppargamma Mutant R357a And Rosiglitazone
1HR0 M ,12,3.7,0.0471,1.3,8.3,Crystal Structure Of Initiation Factor If1 Bound To The 30s Ribosomal Subunit
3PRG A ,17,5.9,0.0166,1.3,0.0,Ligand Binding Domain Of Human Peroxisome Proliferator Activated Receptor
3BC5 A ,19,6.0,0.0155,1.3,0.0,X-Ray Crystal Structure Of Human Ppar Gamma With 2-(5-(3-(2- (5-Methyl-2-Phenyloxazol-4-Yl)ethoxy)benzyl)-2-Phenyl-2h-1, 2,3-Triazol-4-Yl)acetic Acid
2XSS B 2,22,4.5,0.0184,1.4,13.6,Crystal Structure Of Gafb From The Human Phosphodiesterase 5ÿ
1WM0 X ,18,6.0,0.0155,1.4,0.0,Ppargamma In Complex With A 2-Baba Compound
3LMP A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ppargamma-Lbd Complexed With A Cercosporamide Derivative Modulatorÿ
3AN3 A ,17,5.9,0.0161,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With A Gamma Selective Agonist Mo3sÿ
4NYK A 2,12,3.4,0.0456,1.4,8.3,Structure Of A Membrane Protein
2ZVT B ,17,6.0,0.0120,1.4,0.0,Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed With 15-Deoxy-Delta12,14-Prostaglandin J2ÿ
3D6D A ,17,6.0,0.0124,1.4,0.0,Crystal Structure Of The Complex Between Ppargamma Lbd And The Lt175(R-Enantiomer)ÿ
4OJ4 A ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of V290m Ppargamma Mutant In Complex With Diclofenac
4L96 A ,18,6.0,0.0120,1.4,0.0,Structure Of The Complex Between The F360l Ppargamma Mutant And The Ligand Lt175 (space Group I222)
4IMI B 2,17,3.5,0.0106,1.4,11.8,Novel Modifications On C-terminal Domain Of Rna Polymerase Ii Can Fine- Tune The Phosphatase Activity Of Ssu72
5H9M B 1,13,3.2,0.0479,1.4,7.7,Crystal Structure Of Siah2 Sbd Domain
2Q59 A ,18,6.0,0.0121,1.4,0.0,Crystal Structure Of Ppargamma Lbd Bound To Full Agonist Mrl20
2G0G B ,19,5.8,0.0317,1.4,0.0,Structure-Based Drug Design Of A Novel Family Of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography And In VitroIN VIVO BIOLOGICAL ACTIVITIES
1N3B B 2,12,4.0,0.0351,1.4,16.7,Crystal Structure Of Dephosphocoenzyme A Kinase From Escherichia Coli
4XLD A ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of The Human Pparg-lbd/rosiglitazone Complex Obtained By Dry Co-crystallization And In Situ Diffraction
3V9T A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ppargamma-Lbd Complexed With A Cercosporamide Derivative Modulatorÿ
3V9V A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ppargamma-Lbd Complexed With A Cercosporamide Derivative Modulatorÿ
2Q6S B ,19,6.0,0.0120,1.4,0.0,2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To Bvt.13 Without Co-Activator Peptides
4R06 B ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of Sr2067 Bound To Ppargamma
3H0A D ,18,5.8,0.0343,1.4,0.0,Crystal Structure Of Peroxisome Proliferator-Activated Receptor Gamma (Pparg) And Retinoic Acid Receptor Alpha (Rxra) In Complex With 9-Cis Retinoic Acid, Co-Activator Peptide, And A Partial Agonistÿ
3SZ1 B ,19,6.0,0.0120,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With Luteolin And Myristic Acidÿ
2FLZ C 2,13,3.5,0.0106,1.4,0.0,The X-Ray Structure Of Cis-3-Chloroacrylic Acid Dehalogenase (Cis-Caad) With A Sulfate Ion Bound In The Active Site
3U9Q A ,17,6.0,0.0120,1.4,0.0,Ligand Binding Domain Of Ppargamma Complexed With Decanoic Acid And Pgc-1a Peptideÿ
3B0R B ,17,6.0,0.0120,1.4,0.0,Human Ppar Gamma Ligand Binding Dmain Complexed With Gw9662 In A Covalent Bonded Formÿ
2ZK0 A ,18,6.0,0.0143,1.4,0.0,Human Peroxisome Proliferator-Activated Receptor Gamma Ligand Binding Domainÿ
4JL4 A ,17,6.0,0.0150,1.4,0.0,Crystal Structure Of The Complex Between Ppargamma Lbd And The Ligand Lj570 [(2s)-3-(biphenyl-4-yl)-2-(biphenyl-4-yloxy)propanoic Acid]
3PBA A ,18,6.0,0.0144,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain In Complex With Monosulfate Tetrabromo-Bisphenol A (Monotbbpa)ÿ
4CI5 B ,19,6.0,0.0120,1.4,0.0,Structural Basis For Gl479 A Dual Peroxisome Proliferator- Activated Receptor Gamma Agonist
3ET0 B ,19,6.0,0.0120,1.4,0.0,Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)- Propionic Acidÿ
2OM9 A ,19,6.0,0.0130,1.4,0.0,Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
3IA6 B ,19,6.0,0.0120,1.4,0.0,X-Ray Crystal Structure Of The Nuclear Hormone Receptor Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL Agonistÿ
3V9Y A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ppargamma-Lbd Complexed With A Cercosporamide Derivative Modulatorÿ
4F9M A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ppargamma-Lbd Complexed With A Cercosporamide Derivative Modulator
3B1M A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ppargamma-Lbd Complexed With A Cercosporamide Derivative Modulator Cerco-Aÿ
4YT1 B ,19,6.0,0.0120,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With A Gammma Selective Synthetic Partial Agonist Mekt76
4L98 B ,17,6.0,0.0150,1.4,0.0,Crystal Structure Of The Complex Of F360l Ppargamma Mutant With The Ligand Lt175
4L98 B 1,17,6.0,0.0150,1.4,0.0,Crystal Structure Of The Complex Of F360l Ppargamma Mutant With The Ligand Lt175
3SZ1 A ,18,6.0,0.0120,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With Luteolin And Myristic Acidÿ
1NYX A ,17,5.9,0.0262,1.4,0.0,Ligand Binding Domain Of The Human Peroxisome Proliferator Activated Receptor Gamma In Complex With An Agonist
1ZGY A ,19,6.0,0.0120,1.4,0.0,Structural And Biochemical Basis For Selective Repression Of The Orphan Nuclear Receptor Lrh-1 By Shp
2OM9 C ,19,6.0,0.0134,1.4,0.0,Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
2F4B A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ligand Binding Domain Of Human Ppar-Gamma In Complex With An Agonist
3CS8 A ,19,6.0,0.0120,1.4,0.0,Structural And Biochemical Basis For The Binding Selectivity Of Pparg To Pgc-1a
3WMH A ,17,6.0,0.0140,1.4,0.0,Human Pprr Gamma Ligand Binding Domain In Complex With A Gammma Selective Synthetic Partial Agonist Mekt75
4HEE X ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of Ppargamma In Complex With Compound 13
2Q6S A ,18,6.0,0.0141,1.4,0.0,2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To Bvt.13 Without Co-Activator Peptides
2POB B ,19,6.0,0.0120,1.4,0.0,Ppargamma Ligand Binding Domain Complexed With A Farglitazar Analogue Gw4709
3NFF F ,22,5.0,0.0160,1.4,18.2,Crystal Structure Of Extended Dimerization Module Of Rna Polymerase I Subcomplex A49A34.5ÿ
2HWR A ,19,6.0,0.0120,1.4,0.0,Structural Basis For The Structure-Activity Relationships Of Peroxisome Proliferator-Activated Receptor Agonists
3ADT A ,18,6.0,0.0157,1.4,0.0,Human Ppargamma Ligand-Binding Domain In Complex With 5-Hydroxy-Indole Acetateÿ

4Y29 A ,19,6.0,0.0155,1.4,0.0,Identification Of A Novel Pparg Ligand That Regulates Metabolism
3WJ4 B ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain In Complex With Tributyltin
3WJ5 B ,19,5.8,0.0303,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain In Complex With Triphenyltin
3ADT B ,19,5.9,0.0161,1.4,0.0,Human Ppargamma Ligand-Binding Domain In Complex With 5-Hydroxy-Indole Acetateÿ
2ZK4 A ,18,6.0,0.0135,1.4,0.0,Human Peroxisome Proliferator-Activated Receptor Gamma Ligand Binding Domain Complexed With 15-Oxo- Eicosatetraenoic Acidÿ
4L98 A ,18,5.2,0.0429,1.4,0.0,Crystal Structure Of The Complex Of F360l Ppargamma Mutant With The Ligand Lt175
4L98 A 1,18,5.2,0.0429,1.4,0.0,Crystal Structure Of The Complex Of F360l Ppargamma Mutant With The Ligand Lt175
5EJB C 3,14,3.4,0.0423,1.4,7.1,Crystal Structure Of Prefusion Hendra Virus F Protein
5EJB F 2,14,3.4,0.0365,1.4,7.1,Crystal Structure Of Prefusion Hendra Virus F Protein
5EJB A 3,14,3.4,0.0378,1.4,7.1,Crystal Structure Of Prefusion Hendra Virus F Protein
3VJI B ,19,6.0,0.0155,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With Jkpl53
4EMA B ,18,6.0,0.0120,1.4,0.0,Human Peroxisome Proliferator-activated Receptor Gamma In Complex With Rosiglitazone
2ATH A ,17,6.0,0.0120,1.4,0.0,Crystal Structure Of The Ligand Binding Domain Of Human Ppar-Gamma Im Complex With An Agonist
3R5N A ,18,6.0,0.0120,1.4,0.0,Crystal Structure Of Ppargammalbd Complexed With The Agonist Magnololÿ
2G0G A ,19,6.0,0.0142,1.4,0.0,Structure-Based Drug Design Of A Novel Family Of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography And In VitroIN VIVO BIOLOGICAL ACTIVITIES
4DV2 M ,12,4.0,0.0244,1.4,8.3,Crystal Structure Of The Thermus Thermophilus 30s Ribosomal Subunit With A 16s Rrna Mutation, C912a
2I4J A ,18,6.0,0.0120,1.4,0.0,Crystal Structure Of The Complex Between Ppargamma And The Agonist Lt160 (Ureidofibrate Derivative)
2VV4 B ,19,6.0,0.0120,1.4,0.0,Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
3ADV A ,19,6.0,0.0134,1.4,0.0,Human Ppargamma Ligand-Binding Domain In Complex With Serotoninÿ
2ZK1 A ,18,6.0,0.0146,1.4,0.0,Human Peroxisome Proliferator-Activated Receptor Gamma Ligand Binding Domain Complexed With 15-Deoxy-Delta12,14- Prostaglandin J2ÿ
2XKW B ,18,6.0,0.0120,1.4,0.0,Ligand Binding Domain Of Human Ppar-Gamma In Complex With The Agonist Pioglitazoneÿ
4EMA A ,17,5.9,0.0214,1.4,0.0,Human Peroxisome Proliferator-activated Receptor Gamma In Complex With Rosiglitazone
4EM9 B ,19,6.0,0.0120,1.4,0.0,Human Ppar Gamma In Complex With Nonanoic Acids
2ZK5 B ,19,6.0,0.0120,1.4,0.0,Human Peroxisome Proliferator-Activated Receptor Gamma Ligand Binding Domain Complexed With Nitro-233ÿ
3LYV D ,31,5.1,0.0013,1.4,12.9,Crystal Structure Of A Domain Of Ribosome-Associated Factor Streptococcus Pyogenes Serotype M6. Northeast Structural Ge Consortium Target Id Dr64aÿ
4CI5 A ,18,6.0,0.0120,1.4,0.0,Structural Basis For Gl479 A Dual Peroxisome Proliferator- Activated Receptor Gamma Agonist
2ZVT A ,19,6.0,0.0120,1.4,0.0,Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed With 15-Deoxy-Delta12,14-Prostaglandin J2ÿ
2VV4 A ,18,6.0,0.0120,1.4,0.0,Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
3OSW B ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain In Complex With Tetrabromo-Bisphenol A (Tbbpa)ÿ
3AN4 A ,18,5.9,0.0165,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With A Gamma Selective Agonist Mo4rÿ
4XTA B ,19,5.2,0.0393,1.4,0.0,Mechanisms Of Ppargamma Activation By Non-steroidal Anti-inflammatory Drugs
1NYX B ,19,6.0,0.0120,1.4,0.0,Ligand Binding Domain Of The Human Peroxisome Proliferator Activated Receptor Gamma In Complex With An Agonist
2I4P A ,19,6.0,0.0129,1.4,0.0,Crystal Structure Of The Complex Between Ppargamma And The Partial Agonist Lt127 (Ureidofibrate Derivative). Structure Obtained From Crystals Of The Apo-Form Soaked For 30 Days
2Q61 B ,18,6.0,0.0120,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain Bound To Partial Agonist Sr145
1ZEO B ,19,6.0,0.0139,1.4,0.0,Crystal Structure Of Human Ppar-Gamma Ligand Binding Domain Complexed With An Alpha-Aryloxyphenylacetic Acid Agonist
2Q8S A ,18,6.0,0.0150,1.4,0.0,X-Ray Crystal Structure Of The Nuclear Hormone Receptor Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL Agonist
3B0Q A ,18,6.0,0.0152,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With Mcc555ÿ
3K8S B ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of Pparg In Complex With T2384ÿ
3B3K B ,19,6.0,0.0120,1.4,0.0,Crystal Structure Of The Complex Between Ppargamma And The Full Agonist Lt175
3WJ5 A ,17,6.0,0.0143,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain In Complex With Triphenyltin
3NOA A ,17,6.0,0.0138,1.4,0.0,Crystal Structure Of Human Ppar-Gamma Ligand Binding Domain Complex With A Potency Improved Agonistÿ
2VV2 A ,19,6.0,0.0138,1.4,0.0,Hppargamma Ligand Binding Domain In Complex With 5-Hepa
4BCR A ,17,6.0,0.0141,1.4,0.0,Structure Of Pparalpha In Complex With Wy14643
2VV1 A ,19,6.0,0.0125,1.4,0.0,Hppargamma Ligand Binding Domain In Complex With 4-Hdha
3S9S A ,18,6.0,0.0120,1.4,0.0,Ligand Binding Domain Of Ppargamma Complexed With A Benzimidazole Partial Agonist
3MHS C 1,15,3.2,0.0353,1.4,0.0,Structure Of The Saga Ubp8SGF11SUS1SGF73 DUB MODULE BOUND To Ubiquitin Aldehydeÿ
2ZNO B ,19,6.0,0.0120,1.4,0.0,Human Pprr Gamma Ligand Binding Domain In Complex With A Synthetic Agonist Tipp703ÿ
3VJI A ,19,6.0,0.0135,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With Jkpl53
3OSW A ,18,5.9,0.0220,1.4,0.0,Crystal Structure Of Ppargamma Ligand Binding Domain In Complex With Tetrabromo-Bisphenol A (Tbbpa)ÿ
1FM9 D ,17,6.0,0.0137,1.4,0.0,The 2.1 Angstrom Resolution Crystal Structure Of The Heterodimer Of The Human Rxralpha And Ppargamma Ligand Binding Domains Respectively Bound With 9-Cis Retinoic Acid And Gi262570 And Co-Activator Peptides
1FM6 D ,17,5.9,0.0177,1.4,0.0,The 2.1 Angstrom Resolution Crystal Structure Of The Heterodimer Of The Human Rxralpha And Ppargamma Ligand Binding Domains Respectively Bound With 9-Cis Retinoic Acid And Rosiglitazone And Co-Activator Peptides
2I4Z A ,19,6.0,0.0156,1.4,0.0,Crystal Structure Of The Complex Between Ppargamma And The Partial Agonist Lt127 (Ureidofibrate Derivative). This Structure Has Been Obtained From Crystals Soaked For 6 Hours
2Q5P A ,18,6.0,0.0132,1.4,0.0,Crystal Structure Of Ppargamma Bound To Partial Agonist Mrl24
3B0Q B ,18,6.0,0.0120,1.4,0.0,Human Ppar Gamma Ligand Binding Domain In Complex With Mcc555ÿ
3ADX B ,19,6.0,0.0120,1.4,0.0,Human Ppargamma Ligand-Binding Domain In Complex With Indomethacin And Nitro-233ÿ
2ZK1 B ,17,6.0,0.0145,1.4,0.0,Human Peroxisome Proliferator-Activated Receptor Gamma Ligand Binding Domain Complexed With 15-Deoxy-Delta12,14- Prostaglandin J2ÿ
2CT1 A 2,14,3.3,0.0314,1.4,0.0,Solution Structure Of The Zinc Finger Domain Of Transcriptional Repressor Ctcf Proteinÿ
4XTA A ,18,6.0,0.0120,1.4,0.0,Mechanisms Of Ppargamma Activation By Non-steroidal Anti-inflammatory Drugs
2P4Y B ,17,5.2,0.0449,1.4,0.0,Crystal Structure Of Human Ppar-Gamma-Ligand Binding Domain Complexed With An Indole-Based Modulator
4E4Q A ,19,6.0,0.0157,1.4,0.0,Crystal Structure Of Ppargamma With The Ligand Fs214
